In-house & bespoke training:
Biopharma

Biopharmaceuticals, known colloquially as biopharma, are the point at which biotechnology and pharmaceutical manufacturing meet. Biopharma is the application of living organisms or extractions, by-products or components of living organisms, to prevent, relieve, or treat diseases.

Management Forum’s biopharma training courses provide an extensive series of training opportunities covering a variety of topics, including the development of biopharmaceuticals, clinical trial requirements, manufacture, regulations and applicable standards. Our courses also provide insight into the use of emerging technologies and state-of-the-art processes.  

 

Please note: full product details will be shown on our training portal IPI Academy where you can find out more and book

Biosimilars

In-house & bespoke training

A two-day seminar providing an essential overview of biosmilars and how they differ from the original biological product.

Rated by attendees to the public programme

Typically presented by Andrew Willis (bio)

Typical duration: 2 days
Pricing from £1,000 per attendee
Delivery: collaborative classroom

More @ IPI Academy

Biotechnology for the Non-Biotechnologist

In-house & bespoke training

An ideal course for non-scientists and scientists who need to understand the basic theory, principles, techniques and potential of biotechnology.

Rated by attendees to the public programme

Typically presented by Robert Alvarez (bio)
and 6 more leading experts

Typical duration: 3 days
Pricing from £1,350 per attendee
Delivery: collaborative classroom

More @ IPI Academy

Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products

In-house & bespoke training

The regulatory requirements for Biological drug products are complex, and pharmaceutical companies are continuously under pressure to ensure regulatory compliance from drug discovery to post-marketing surveillance.
This course has been designed to help you navigate the complex regulatory requirements for biological drugs, including ATMPs. It will clearly depict the differences between small and large molecules and the development approaches which reflect the type of molecule. It will address the key aspects of the CTD, look at the CMC regulatory requirements during different stages of development, and discuss the importance of change control.

Rated by attendees to the public programme

Typically presented by Andrew Willis (bio)

Typical duration: 2 days
Pricing from £1,000 per attendee
Delivery: collaborative classroom

More @ IPI Academy

Molecular Biology for the Non-molecular Biologist

In-house & bespoke training

Explore the applications and significance of molecular biology in the pharmaceutical industry, covering DNA, RNA, proteins, gene expression, biotechnology, drug discovery, personalised medicine, and the latest breakthroughs like CRISPR-Cas9 and mRNA vaccines.

Rated by attendees to the public programme

Typically presented by Sayed Goda (bio)

Typical duration: 2 days
Pricing from £1,000 per attendee
Delivery: collaborative classroom

More @ IPI Academy

Protein Engineering for Pharmaceutical Biotechnology

In-house & bespoke training

Advance your expertise in protein engineering with this comprehensive course. Learn cutting-edge techniques in therapeutic development, biotechnology applications, and regulatory compliance, ideal for professionals in pharmaceutical and industrial sectors.

Typically presented by Sayed Goda (bio)

Typical duration: 2 days
Pricing from £1,000 per attendee
Delivery: collaborative classroom

More @ IPI Academy

The Applications of Nanoparticles in the Pharmaceutical and Biomedical Industries

In-house & bespoke training

Attendees will gain a comprehensive understanding of the science behind nanoparticles, their diverse applications, manufacturing and the opportunities and challenges involved in bringing nanoparticle-based solutions to market.

Typically presented by Mohammed Alkattan (bio)

Pricing from £1,000 per attendee
Delivery: collaborative classroom

More @ IPI Academy

US FDA - Understanding Key Factors When Working with the FDA

In-house & bespoke training

This course has been designed to provide an essential overview of the critical factors when working with the FDA (Food and Drug Administration).  For those short on time this course is for you, as you will receive a focused and comprehensive overview of the key strategic considerations when making applications to the FDA.  

Rated by attendees to the public programme

Typically presented by Andrew Willis (bio)

Typical duration: 1 day
Pricing from £500 per attendee
Delivery: collaborative classroom

More @ IPI Academy

Training options

All of our course outlines are available:
Ready made for any number of participants or With a programme and presenters customised to your requirements
And in your preferred format, or combination:
Face-to-face training at your location or Webinar/interactive online

Previous attendees said...

“I wanted to get a good overview of biotechnology: history, development, science, processes, regulations and future and this goal was 100% fulfilled.

All lecturers were highly competent in terms of content and style of presentation.”

Andy Bossert, CQV Engineer, Lonza

“All of the speakers were very knowledgeable, well prepared and presented the topics in a structured and comprehensible manner. A session I thought would be rather arid turned out to be entertaining and instructive at the same time. The seminar gave a very complete overview of the topics.”

Max Hofferberth, DSTL, Hoffmann LaRoche

“Excellent, I am so please a colleague mentioned to IPI to me. ”

Julie Bailey, CFO, ILC Therapeutics Ltd

“Content flow is well designed and good. [Parts I particularly liked were] process economy , Upstream and Downstream scale up.”

Arindam Gupta, Global Category Procurement Manager, Servier Monde

“I wanted to get short insight into biosimilar development process and I completely accomplished it. ”

Ainars Gavarans, , Olainfarm AS

“Content was informative, I've learned many new details and subjects to consider. Speaker was fluent and interactive. I'll recommend this course to new QP's in the future. ”

Lian Abu-Obed, QP Trainee, Unipharm Limited

“The speaker had lots of clarity in his explanations, making the course very easy to follow and understand, even with deep topics.”

Bernardo Diaz, Regulatory Affairs Manager, Bioeq AG

“
”

Thomas Lehmann Falck, , Novo Nordisk Denmark

“Good webinar, presentation and excellent speakers”

Nor Hazwan Ali, Head of Regulatory Affairs,

“The Webinar gave me a lot of information around FDA [particularly] on general information/introduction to FDA Overall, [the speaker] was very good in explaining the topics and also in responding to the various questions. It was a useful webinar, and I would recommend it to others who aren't that familiar with the FDA/general legislation.”

Judith Handwerger, Manager Regulatory Affairs, Alfred E. Tiefenbacher (GmbH & Co. KG)